Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Baak-Pablo, R.F.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(8)
+
-
Availability
Open access
(1)
+
-
Metadata Only
(7)
+
-
Creation Date
2011
(2)
+
-
2014
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(8)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(8)
+
-
Topic
pharmacogenetics
(3)
+
-
type 2 diabetes mellitus
(2)
+
-
Author
Baak-Pablo, R.F.
(8)
+
-
Guchelaar, H.J.
(8)
+
-
Straaten, R.J.H.M. van der
(4)
+
-
Swen, J.J.
(4)
+
-
Gelderblom, H.
(2)
+
-
Nortier, J.W.R.
(2)
+
-
Pullen, C.M.C.
(2)
+
-
Wessels, J.A.M.
(2)
+
-
Show more
Language
en
(8)
+
-
Search results
(1 - 8 of 8)
show grid
show list
save search
Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
Clinical validation study of genetic markers for capecitabine efficacy in metastatic colorectal cancer patients
SIMVASTATIN CAUSES TRANSLOCATION OF MUTANT K-RAS IN COLORECTAL CANCER CELLS
Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial
Simvastatin induces KRAS translocation in KRAS mutant colorectal cancer cells and may influence the susceptibility to anti-EGFR therapy
Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1 beta gene
Association of ABCB1, 5-HT3B Receptor and CYP2D6 Genetic Polymorphisms with Ondansetron and Metoclopramide Antiemetic Response in Indonesian Cancer Patients Treated with Highly Emetogenic Chemotherapy
Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment